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INTRODUCTION
Insulin maintains glucose homeostasis by en-
hancing glucose transport into muscle and adipose
tissues, a process mediated by recruitment of GLUT4
storage vesicles to the cell surface where these ves-
icles are first tethered, then docked and fused with
the plasma membrane (1). One class of proteins
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that function in this docking/fusion step are SNARE
proteins (2), of which the vesicle SNARE VAMP2,
and the t-SNAREs, syntaxin 4 and SNAP23 are the
best characterized (3, 4). The SNARE core is ex-
tremely energetically stable; thus, the timing of its
formation and subsequent dissociation is likely to
be regulated by SNARE-associated proteins, such
as Munc-18c, tomosyn, and synip (4).
Cysteine string protein 1 (CSP1) plays the role
of a SNARE-binding protein or a chaperone and is
expressed mainly in neuronal cells and also in cells
such as adipocytes and islet cells (5-10). CSP1 is es-
sential for presynaptic neurotransmission and also
influences regulation of exocytosis in PC12 and
pancreatic β -cells (10-13). Recent genetic and bio-
chemical analyses have revealed a functional inter-
action of CSP with the syntaxin family or VAMP2
in neurons (11, 14-16). In addition, in vitro phos-
phorylation studies have revealed that Akt and PKA
phosphorylate CSP1 (7, 17, 18). These findings sug-
gest that CSP1 may be one of the proteins partici-
pating in insulin-stimulated GLUT4 trafficking at a
step or steps close to the plasma membrane.
The molecular mechanism by which insulin stimu-
lates the translocation, tethering, docking and fusion
of GLUT4 to the cell surface has been extensively
studied, but many details of insulin signaling link-
ing specific molecules to these processes remain in-
completely described, particularly those evens most
proximal to the plasma membrane. The aim of the
present study was to determine the role of CSP1 in
processes regulating GLUT4-containing vesicles as
they translocate to the plasma membrane. The re-
sults of this study indicate that CSP1 is a candidate
insulin resistance protein by virtue of its ability to
interrupt GLUT4 vesicle docking via blocking the
binding of the v-SNARE, VAMP2 on GLUT4 ves-
icles to t-SNARE, syntaxin 4 on the plasma mem-
brane.
MATERIALS AND METHODS
Materials
0.25% trypsin-EDTA, penicillin/streptomycin, and
pcDNA 3.1 vector were purchased from Life Tech-
nologies (Carlsbad, CA). ECL detection kit and
bicinchoninic acid (BCA) protein assay kits were
purchased from Thermo Scientific (Rockford, IL).
Dulbecco’s modified Eagle’s medium (DMEM),
Dulbecco’s PBS without Mg++ or Ca++ (D-PBS),
dexamethasone, and 3-isobutyl-1-methylxanthine
(IBMX) were obtained from Sigma-Aldrich (St.
Louis, MO). Insulin was purchased from Wako
(Osaka, Japan), and troglitazone was from Cayman
Chemical (Ann Arbor, MI). Protein A-agarose, 2-
deoxy-D-glucose and scintillation counting solution
were from GE Healthcare (Pittsburgh, PA). TaKaRa
PrimeScriptTM RT reagent kits and TaKaRa SYBR
Premix Ex Taq were from Takara Bio (Kyoto,
Japan). pcDNA 3 myc bovine CSP1(CSP1-Myc) and
pcDNA 3 myc bovine CSP1 whose serine 10 was
mutated to alanine (S10ACSP-Myc) were a kind
gift from Professor Alan Morgan at University of
Liverpool (7). pcDNA3 myc GLUT4 construct (Myc-
GLUT4) containing an myc epitope tag in the first
exofacial loop of GLUT4 was kindly provided by
Dr. Shuichi Okada (Gunma University, Japan). For
small interference RNA (siRNA), constructs Mouse
Dnajc5 (SMF27A-0991-2 or 3), siCSP1 and non-tar-
geting siRNA control, siControl (S10CM-0600) were
obtained from B-Bridge International (Sunnyvale,
CA). All other chemicals were of analytical grade.
Antibodies
CSP1 antibody was obtained from Stress gen
(Victoria, BC). VAMP2 antibody and syntaxin 4
antibody were purchased from Synaptic Systems
(Gottingen, Germany). GLUT1 antibody was from
Biogenesis, (Hackensack, NJ). Akt antibody and p-
Akt (Ser473) antibody were from Cell Signaling
Technology (Beverly, MA). GLUT4 antibody was
raised and purified as described previously (19).
HRP-conjugated IgG second antibodies were pur-
chased from Life Technologies (Carlsbad, CA).
Cell culture
3T3-L1 fibroblasts were induced to differentiate
as described previously with minor modification
(19). Briefly, 3T3-L1 fibroblasts were cultured in
15 cm dishes for electroporation with DMEM con-
taining 4.5 g/l glucose, L-glutamine and 10% calf
serum. Two days after confluence, cells were in-
duced to differentiate by changing media to DMEM
supplemented with 10% FBS, 0.5 mM IBMX, 1 μM
dexamethasone, 1.7 μM insulin, and 1 μM trogli-
tazone. After 48 h of induction, the medium was
changed to DMEM supplemented with 10% FBS,
and cells were fed with fresh medium every other
day thereafter. Cells were used for experiments 8
days after inducing differentiation, when 90% of
the cells expressed the adipocyte phenotype.
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Electroporation into 3T3-L1 adipocytes
This protocol was performed as described previ-
ously (20). Briefly, differentiated 3T3-L1 adipocytes
were dislodged by incubation with trypsin-EDTA
and centrifuged at 900 rpm for 3 min at room tem-
perature (RT). Adipocytes were suspended again in
D-PBS to an approximate concentration of 1.0107
cells/500 μl and pipetted into a cuvette with a 0.4
cm electrode gap with 400 μg pcDNA3.1 plasmid,
CSP1-Myc plasmid or S10ACSP1-Myc plasmid (and
without or with 400 μg of Myc-GLUT4 for colorimet-
ric assay, respectively). For RNA silencing, 2 nM
siCSP1 or siControl was electroporated. This mix-
ture was charged with 950 μF capacitance at 0.16
kV in a Gene Pulser II apparatus (Bio-Rad Labora-
tories, Hercules, CA), and then cells were immedi-
ately transferred to a tube containing warmed 10%
FBS in DMEM and incubated at RT. After 10 min
of incubation, the cells were plated for experiments.
About 12 h after electroporation, cells were fed with
new 10% FBS in DMEM, and until 48 h post-electro-
poration, cells were serum starved for at least 4 h
before use in experiments.
Western blot analysis
After treatment of the cells as described in the
figure legends, they were lysed in RIPA buffer.
Cell lysates were obtained by centrifugation at
13,000 rpm for 20 min at 4, and protein content
of each sample was determined by the BCA method.
Equal amounts of proteins were subjected to sodium
dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE). Gels were transferred to an Immo-
bilon-P membrane (Millipore, Bedford, MA). Im-
munoblotting was performed with an ECL system
according to the manufacturer’s instructions. Den-
sitometric analysis was performed using Image J
1.38software (NIH, Bethesda, MD).
Glucose uptake assay
This protocol was carried out as described pre-
viously with minor alterations (19). Electroporated
3T3-L1 adipocytes were serum-starved for 4 h with
serum-free DMEM and then cells were stimulated
or not with 100 nM insulin for 15 min following pre-
incubation for 30 min with Krebs Ringer phosphate
buffer (KRP), pH 7.4. Glucose uptake was measured
by incubation with 1 mM 2-deoxy D-glucose con-
taining 1 μCi/ml 2-deoxy D-glucose for 4 min at
37. Cells were solubilized with PBS with 0.1%
Triton X-100, and the radioactivity was detected by a
liquid scintillation counter LSC-6100 (Aloka, Tokyo,
Japan). Nonspecific 2-deoxy D-glucose uptake was
measured in the presence of 1 μl of 120 mM phlo-
retin/well and this value was subtracted from each
determination to obtain specific uptake.
Immunoprecipitation (IP)
3T3-L1 adipocytes electroporated with siRNA
were serum-starved for 4 h and treated with or with-
out 100 nM insulin for 15 min. Cell lysates were
obtained as described in ‘Western Blot Analysis’.
VAMP2 antibody (1 μg) was added to 2 mg pro-
tein and mixed at 4overnight by rotation. Then
50 μl protein A plus sepharose beads were added
and the mixture was rotated for 3 h at 4. Subse-
quently, the antibody-coupled beads were washed
three times with RIPA buffer by centrifuging at
5,000 rpm for 2 min at 4. Finally, beads were
mixed with SDS-PAGE sample buffer for Western
blotting analysis. Before running gel electrophore-
sis, samples were boiled at 100for 5 min.
Colorimetric assay for detecting plasma membrane
Myc-GLUT4 proteins
3T3-L1 adipocytes electroporated with 400 μg of
CSP1-Myc or pcDNA3.1 plasmid plus 400 μg Myc-
GLUT4 were reseeded onto a 24-well plate. After 48
h, wells were washed twice with serum-free DMEM
at 37and incubated with DMEM with 0.2% BSA
for 4 h. Then wells were washed twice with KRP
buffer at RT and incubated with KRP buffer for 30
min at 37without or with 100 nM insulin. The
dish was then locked on ice and fixed with 3.7% for-
maldehyde in PBS for 5 min. After washing several
times with PBS, non-specific binding of the cells
was blocked by 0.1 N glycine in PBS for 15 min at
RT. Cells were incubated with myc antibody at a di-
lution of 1 : 1000 for 2 h at RT incubated and then
with HRP-conjugated antibody in KRP with 0.1%
BSA at a dilution of 1 : 1000 for 1 h, and finally the
intensity value of ECL reaction was read by using
Infinite F500 (TECANMännedorf, Switzerland).
Subcellular membrane fractionation
Subcellular fractionations were performed as de-
scribed in our previous report (19) with slight modi-
fication. Specifically, 3T3-L1 adipocytes were serum-
starved for 4 hours at 37and then glucose-starved
with KRP buffer, pH 7.4 for 30 min at 37. Subse-
quently, cells were treated with 100 nM insulin for
15 min at 37. Then the cells were scraped into
HES (2 mM HEPES, pH 7.4, 5 mM EDTA and 250
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mM sucrose) supplemented with protease inhibitor
cocktail, and homogenized with 8 passages through
a 29 gauge syringe. The homogenate was centri-
fuged at 19,000 g for 20 min at 4to precipitate cel-
lular debris. The pellet was then suspended in HES
buffer, layered onto a sucrose cushion (1.12 M su-
crose), and subjected to ultracentrifuge at 100,000 g
for 60 min at 4. The membrane fraction floating
on the sucrose cushion was collected, resuspended
in HES buffer and centrifuged at 40,000 g for 20 min
at 4. The final pellet, designated as plasma mem-
brane fraction, was resuspended in RIPA buffer and
the same amounts of protein were used for Western
blotting.
RNA extraction and reverse transcription PCR
Total RNA was extracted from 3T3-L1 adipocytes
using TRIzol reagent. After RNA had been treated
with DNase I, 0.5 μg DNA was reverse-transcribed
using TaKaRa PrimeScriptTM RT reagent kits accord-
ing to the manufacturer’s instructions.
Quantitative real-time PCR
Quantitative real-time reverse transcription po-
lymerase chain reaction (quantitative real-time RT-
PCR) was performed with a LightCycler system
(Roche Diagnostics, Mannheim, Germany) using
about 100 ng DNA of each reverse-transcribed re-
action. The following oligonucleotide primers were
used : CSP1 5’ -GACGCCACGAAAAGAAACAT-3’
(forward) and 5’ -CAAACAGCAGCAGCAGTAGC-
3’ (reverse) ; 18S ribosomal RNA 5’ -AAACGGCT-
ACCACATCCAAG-3’ (forward) and 5’ -GGCCTC-
GAAAGAGTCCTGTA-3’ (reverse). Samples were
prepared by using TaKaRa SYBR Premix Ex Taq
according to the manufacturer’s instructions and re-
acted in the ligthCycler for PCR. After the reaction,
each PCR product was verified for its single ampli-
fication by melting curve analysis. Expression levels
were normalized to the expression of 18S ribosomal
RNA.
Statistical analysis
P values were calculated using unpaired Student’s
t-test , and p values0.05 were considered as signifi-
cant differences.
RESULTS
CSP1 contributes to insulin-stimulated glucose up-
take at the step of GLUT4-vesicle docking to the
plasma membrane.
First, we confirmed by immuno-fluorescence and
subcellular fractionation that expression of CSP1
increased by about 4-folds after differentiation of adi-
pocytes, that CSP1 existed both in the plasma mem-
brane and intracellular membranes and its localiza-
tion was not affected by insulin (data not shown).
To clarify the role of CSP1 for GLUT4 trafficking,
CSP1 was over-expressed in 3T3-L1 adipocytes by
electroporation (20). As shown in Figure 1, an ap-
proximately 2-fold over-expression of CSP1 protein
did not influence protein expression of glucose trans-
porter 1 (GLUT1), GLUT4, syntaxin 4 and VAMP2,
which are important for GLUT4 vesicle trafficking,
nor did it affect expression of Akt, which are re-
quired for insulin signaling (Figure 1A). Insulin-
stimulated Akt phosphorylation also was not influ-
enced by CSP1 over-expression (Figure 1B). On the
other hand, over-expression of CSP1 significantly
reduced basal and insulin-stimulated glucose uptake
compared to that of control plasmid (Figure 1C).
In order to explain the decrease of insulin-stimu-
lated glucose uptake by over-expressed CSP1 pro-
tein, GLUT4 recruitment to the plasma membrane
was examined (Figure 2A). The amount of GLUT4
that fractionates with the plasma membrane after
CSP1 over-expression was not different from that of
control plasmid over-expression (Figure 2B). After
movement of GLUT4 to the plasma membrane, the
final steps by which GLUT4 vesicle facilitates glu-
cose entry into the cell are tethering, docking and
fusion (21). Thus, both of Myc-GLUT4 and CSP1
were co-expressed (Figure 2C) and the fusion of
GLUT4 vesicles with the plasma membrane was
monitored by Myc-GLUT4 (22). As shown in Figure
2D, surface incorporation of Myc-GLUT4 was sig-
nificantly reduced after over-expression of CSP1
compared to that of the control.
The SNARE complex consisting of syntaxin 4,
VAMP2 and SNAP23, likely constitutes the molecu-
lar scaffold regulating GLUT4 vesicle docking and
fusion to the PM (22). By an in vitro pull down
assay from 3T3-L1 cell lysates, CSP1 was shown to
interact with syntaxin 4 in 3T3-L1 adipocyetes (6).
Therefore, to explore the mechanism of the attenu-
ated GLUT4 insertion in CSP1-over-expressed cells,
binding of VAMP2 to syntaxin 4 was examined by IP.
VAMP2 antibody could not detect CSP1 by co-IP.
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Also efficacy of IP by CSP1 or sytaxin 4 antibody
was poor respectively. As shown in Figures 2E and
F, in CSP1-over-expressed cells, the interaction of
VAMP2 with syntaxin 4 by insulin was significantly
reduced to less than half of control values, which
might be responsible for the inhibition of GLUT4 in-
sertion into the plasma membrane (Figure 2D). Pre-
vious studies reveal that Akt phosphorylates serine
10 site of CSP1 by Ca2+ stimulation in chromaffin
cells and serine-phosphorylated CSP1 influences
Figure 2. Over-expression of CSP1 inhibits SNARE complex formation concomitant with exposure of the cell surface to GLUT4 but
not translocation of GLUT4.
Cells were electroporated with either Control or CSP1-Myc plasmid (A-F) together with Myc-GLUT4 (C, D). Cells were serum-starved
and were either left without (-) or with insulin (+) for 15 min (E, F) or 30 min (A-D). A. Plasma membrane fraction was obtained and
immunoblotted with GLUT4 antibody. Representative results of three independent experiments are presented. B. Results from all three
experiments of A were also quantified, and the fold- increase from Control without insulin is shown. C. Cell lysates were immunoblotted
with either GLUT4 or CSP1 antibody. D. Surface incorporation of Myc-GLUT4 with insulin was quantified as described in the Methods
section. Results from three independent experiments were quantified, and the fold- increase from Control with insulin is shown. E. Insu-
lin-stimulated cell lysates were immunoprecipitated with VAMP2 antibody and immunoblotted with either syntaxin 4 or VAMP2 antibody.
F. Results from three independent experiments of E were quantified and the fold- increase from Control with insulin is shown. Data
shown are meansSEM (N.S. : not significant, *P0.01 compared with Control).
Figure 1. Over-expression of CSP1 decreases insulin-stimulated glucose uptake with-
out affecting insulin-dependent signal transduction.
Cells were electroporated with either Control or CSP1-Myc plasmid. A. Total cell lysates
were immunoblotted with CSP1, VAMP2, GLUT4, GLUT1, syntaxin 4 or 14-3-3 β antibody.
B. Cells were serum-starved and were left without (-) or with insulin (+) for 15 min. Cell
lysates were immunoblotted with either Akt or p-Akt antibody. Representative results of four
(A) or three (B) independent experiments are presented. C. The electroporated cells were
examined by glucose uptake after 0, 7.5, 15 min of insulin stimulation. The results of four
independent experiments are presented as meansSEM (*P0.01 or #P0.05 compared
with Control) and the fold- increase above control without insulin stimulation was shown.
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the binding of syntaxin family members (7). We
checked whether this insulin-stimulated phospho-
rylation of CSP1 involved GLUT4 trafficking. Over-
expression of S10ACSP1 mutant protein decreased
insulin stimulated glucose uptake to a similar extent
as did over-expression of wild type CSP1 (Figure
3A).
To confirm the function of CSP1, it was knocked-
down in 3T3-L1 adipocytes (Figure 3B). Gene si-
lencing of CSP1 led to enhanced insulin-stimulated
glucose uptake (Figure 3C). Knockdown of CSP1
protein did not influence the expression of proteins
involved in insulin-signaling such as Akt and its
phosphorylation by insulin stimulation, or GLUT4
content in the plasma membrane (not shown).
The mRNA and protein expression of CSP1 in 3T3-
L1 adipocytes is increased under insulin resistance
states.
To assess the possible pathological aspects of
CSP1 expression, its mRNA was examined in an
insulin resistance state. Exposure to a high level of
insulin (100 nM) significantly increased mRNA ex-
pression of CSP1 (Figure 4A) under these condi-
tions. Elevated free fatty acid also causes insulin re-
sistance in a diabetic state or obesity (23). As shown
in Figure 4B, incubation with 250 mM palmitate for
24 hours dramatically increased the mRNA expres-
sion of CSP1. Moreover, incubation with both 100
nM insulin and 250 mM palmitate for 48 hours in-
creased the protein expression of CSP1 (Figure 4C).
Figure 3. The effect of gene-manipulated CSP1 on insulin-
stimulated glucose uptake.
A. Cells were electroporated with either Control CSP1-Myc or
S10ACSP1-Myc plasmid. The electroporated cells were examined
by glucose uptake after 0, 15 min of insulin stimulation. The re-
sults of three independent experiments are presented as means
SEM (N.S. : not significant, #P0.05 , *P0.01 compared with
Control) and the fold increase above Control without insulin
stimulation was shown. B. Cells were electroporated with either
siControl or siCSP1 and cell lysates were immunoblotted with
either CSP1 or Akt antibody. C. The electroporated cells were ex-
amined by glucose uptake after 0, 7.5, 15 min of insulin stimula-
tion. The results of four independent experiments are presented
as meansSEM (#P0.05 compared with siControl) and the
fold increase above siControl without insulin stimulation was
shown.
Figure 4. mRNA and protein expression of CSP1 is increased
in an insulin resistant state.
Differentiated 3T3-L1 adipocytes were serum-starved for 4 hours.
A. Cells were treated with or without insulin for 24 hours at 37.
B. The adipocytes were treated with or without palmitate for 24
hours. Total mRNA that had been treated as described in A, B
was extracted from cultured cells and subjected to quantita-
tive real - time PCR with specific primers for CSP1. Results are
meansSEM from three different experiments (*P0.01 com-
pared with untreated condition). C. Total cell lysates of 3T3-L1
adipocyte treated with 100 nM insulin or 250 mM palmitate or
non-treated were immunoblotted with either CSP1 or Akt anti-
body. Representative results of three independent experiments
are presented.
B. Jambaldorj, et al. CSP1 prevents GLUT4 docking202
DISCUSSION
Recent data from a number of laboratories has es-
tablished that a key step in the insulin-dependent-
regulation of GLUT4 translocation requires Akt and
takes place at or very near to the plasma membrane
(24, 25). The individual steps might involve tether-
ing, docking and fusion and the latter two steps
likely involve SNARE proteins. In the current study
of 3T3-L1 adipocytes, it was found that a SNARE-
binding protein, CSP1, participates in GLUT4 vesicle
trafficking to the plasma membrane. Interestingly,
the mRNA and protein expression of CSP1 in insulin
resistant 3T3-L1 adipocytes were elevated, suggest-
ing that CSP1 is closely related to the development
of insulin resistance.
CSP has four isoforms. CSP2 is a splicing isoform
of CSP1. CSPβ and γ are expressed only in the tes-
tis, and the physiological roles of these isoforms are
still not well-understood (5). On the other hand, the
function of CSP1 as a chaperone or a SNARE-bind-
ing protein in neurons has been investigated. It has
been shown that CSP1 binds either to VAMP2 in
neurons (6, 15) or syntaxin 4 in adipocytes (6, 15)
as determined by pull-down protocols. CSP1 might
directly bind either to VAMP2 or syntaxin 4 in vivo ,
but this finding was not confirmed in the present
study, because syntaxin 4 or CSP1 antibodies were
not available for IP (not shown). Also, VAMP2 anti-
body could not detect CSP1 by co-IP. It was specu-
lated that a small fraction of CSP1 might bind to
VAMP2.
Studies in which the effects of suppression or
over-expression of CSP1 in β -cells and PC12 cells
was investigated have shown both positive and nega-
tive results regarding the role of CSP1 in vesicle traf-
ficking (9, 10, 12, 13, 16). The differences observed
in their effects even in the same cell line might be
explained by the differences in methods, i.e., stable
or transient CSP1-over expression, or the difference
in expression levels of CSP1. Moreover, the differ-
ences between β -cells and PC12 cells might be ex-
plained by the different organization of exocytosis
in neuroendocrine cells from that in endocrine cells
(12). As already mentioned, in 3T3-L1 adipocytes,
CSP1 prevented insulin-stimulated GLUT4 vesicle
docking on the plasma membrane when the expres-
sion of CSP1 was over-expressed, that could ex-
plain, in part, the decrease of GLUT4 trafficking in
an insulin resistant state because CSP1 expression
was increased after exposure of high insulin and
palmitate.
Serine-phosphorylated CSP1 influences the bind-
ing of syntaxin family members. In 3T3-L1 adipo-
cytes, over-expression of mutated S10ACSP1 de-
creased insulin-stimulated glucose uptake in the
case of over-expression of wild type CSP1. This ex-
periment suggested that serine phosphorylation of
CSP1 is not involved in GLUT4 vesicle docking.
From of our studies, the precise mechanism of
CSP1 to modulate the interaction of VAMP2 with
syntaxin 4 was still not cleared. To clarify the pre-
cise function of CSP1, we have been trying to clone
a novel protein that binds to CSP1.
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